Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print October 30, 2003, 10.1148/radiol.2293021354
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2293021354v1
229/3/683    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Boom, R.
Right arrow Articles by van Buchem, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Boom, R.
Right arrow Articles by van Buchem, M. A.
(Radiology 2003;229:683-690.)
© RSNA, 2003


Neuroradiology

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: MR Imaging Findings at Different Ages—3rd–6th Decades1

Rivka van den Boom, MD, Saskia A. J. Lesnik Oberstein, MD, Michel D. Ferrari, MD, PhD, Joost Haan, MD, PhD and Mark A. van Buchem, MD, PhD

1 From the Departments of Radiology (R.v.d.B., M.A.v.B.), Clinical Genetics (S.A.J.L.O.), and Neurology (M.D.F., J.H.), Leiden University Medical Center, C2S, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; and Department of Neurology, Rijnland Hospital, Leiderdorp, the Netherlands (J.H.). From the 2002 RSNA scientific assembly. Received October 22, 2002; revision requested January 7, 2003; final revision received April 16; accepted May 20. Address correspondence to R.v.d.B. (e-mail: r.van_den_boom@lumc.nl).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To depict various brain lesions that have been described in patients who have cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) with prospective standardized magnetic resonance (MR) imaging in patients of different age groups.

MATERIALS AND METHODS: Forty patients with CADASIL in different age groups (20–30 years, n = 5; 31–40 years, n = 4; 41–50 years, n = 16; 51–60 years, n = 15) underwent transverse MR imaging with T1-weighted dual fast spin-echo, fluid-attenuated inversion-recovery, and T2*-weighted gradient-echo sequences. Images were analyzed by one neuroradiologist for the presence of areas of hyperintensity, lacunar infarcts, microbleeds, and subcortical lacunar lesions (SLLs) in different anatomic locations. Descriptive statistics were obtained for the presence of MR imaging abnormalities in various brain areas and for distribution according to age.

RESULTS: The mean age of the 40 mutation carriers (21 women, 19 men) was 45 years ± 10 (SD). In patients with CADASIL who were 20–30 years old, characteristic hyperintense lesions in the anterior temporal lobe (100% [five of five]) and SLLs (20% [one of five]) were the only abnormalities seen on MR images. In patients who were 30–40 years old, lacunar infarcts were found in 75% (three of four) of cases. More areas of hyperintensity were noted, and they frequently involved the external capsule, basal ganglia, and brainstem. In patients 41–50 years old, microbleeds were observed in 19% (three of 16). In patients older than 50 years, areas of hyperintensity (100% [15 of 15]), SLLs (73% [11 of 15]), lacunar infarcts (93% [14 of 15]), and microbleeds (47% [seven of 15]) were frequently observed.

CONCLUSION: The four types of brain lesions that are observed in patients with CADASIL were seen in patients of different age groups.

© RSNA, 2003

Index terms: Brain, diseases, 13.78, 13.87 • Brain, infarction • Brain, MR, 13.121411, 13.121412, 13.121413 • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), 10.7229


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited systemic disease of the small artery caused by mutations in the NOTCH3 gene on chromosome 19 (1). Histopathologic studies of the small and medium-sized leptomeningeal arteries and the long perforating arteries of the brain revealed luminal narrowing or even obliteration caused by deposition of electron-dense granular material close to the membrane of the vascular smooth muscle cells, as well as loss of vascular smooth muscle cells (2). Clinical manifestations of the disease include ischemic stroke, dementia, migraine with aura, and mood disturbances (3). The first clinical manifestations of the disease often start in patients during the 3rd decade, and death often occurs in patients during the 6th decade (3). Main magnetic resonance (MR) imaging findings in patients with CADASIL are diffuse areas of hyperintensity of white matter thatoccur predominantly in the subcortical areas and lacunar infarcts that are present in the semiovale center, the thalamus, the basal ganglia, and the pons (46). Recent MR imaging study findings demonstrated microbleeds and subcortical lacunar lesions (SLLs) as additional radiologic features of CADASIL (79).

The definite diagnosis of CADASIL is established with detection of NOTCH3 mutations, and detection of these mutations is a laborious process that is performed at a limited number of specialized centers. Presently, NOTCH3 mutation analysis is considered only in patients who have unexplained neurologic symptoms, such as ischemic episodes, cognitive deficits, and a positive family history of these symptoms, and who have suggestive MR imaging abnormalities. The radiologic findings of patients with advanced stages of the disease are well documented. On the basis of these descriptions, radiologists can adequately help in the identification of patients with an indication for further molecular or pathologic testing for CADASIL (46,1012). However, the radiologic appearances during earlier stages of the disease have not been described in detail, and this lack of information may lead to inadequate guidance of patients through the diagnostic work-up.

To our knowledge, findings of the only published study about the development of cerebral changes over time in patients with CADASIL were reported by Chabriat et al (5). In that study, the development of areas of hyperintensity and of lacunar infarcts was studied in the periventricular and subcortical white matter, the basal ganglia, and the infratentorial areas. However, after publication of that study, other radiologic hallmarks of CADASIL, such as SLLs, microbleeds, and areas of hyperintensity in the anterior temporal lobe and in the external capsule, were detected (79,11). The temporal evolution of these more recently described radiologic phenomena of CADASIL remains to be elucidated. Thus, the purpose of our study was to depict various brain lesions that have been described in patients who have CADASIL with prospective performance of standardized MR imaging in patients of different age groups.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Members of 15 unrelated Dutch families who had CADASIL were asked to participate in a study about the clinical, radiologic, and genetic aspects of CADASIL in patients from the Netherlands. In each family, at least one member had a confirmed NOTCH3 mutation. These patients were referred to Leiden University Medical Center from various medical centers; this institution serves as a national CADASIL referral center. The total number of participants was 63 and included symptomatic, as well as asymptomatic, family members. Participants were considered symptomatic when they had a history of neurologic deficits or cognitive decline. The diagnosis of CADASIL was confirmed after the MR imaging examination with identification of pathogenic mutations of the NOTCH3 gene, as previously described (13).

The families included in this study were all of the families seen between August 1999 and July 2000. To ensure informed consent, only cognitively capable subjects were included in this study. The institutional medical ethics committee approved the study protocol. Since one individual of the 63 participants did not consent to undergo MR imaging, the final number of subjects was 62; 40 of these subjects had a mutation in the NOTCH3 gene and 22 did not.

MR Imaging and Interpretation
All MR imaging examinations were performed with a 1.5-T MR system (Philips Medical systems, Best, the Netherlands). Participants underwent MR imaging with a standardized protocol that included the following: conventional T1-weighted spin-echo (repetition time msec/echo time msec, 600/20; section thickness, 6.0 mm; intersection gap, 0.6 mm; matrix, 256 x 205; field of view, 220 x 165 mm), dual T2-weighted fast spin-echo (3,000/27, 120; section thickness, 3.0 mm; intersection gap, 0 mm; matrix, 256 x 205; field of view, 220 x 220 mm), and fast fluid-attenuated inversion-recovery (FLAIR) (repetition time msec/echo time msec/inversion time msec, 8,000/100/2,000; section thickness, 3.0 mm; intersection gap, 0 mm; matrix, 256 x 192; field of view, 220 x 176 mm) sequences. In addition, a T2*-weighted gradient echo planar (2,598/48; section thickness, 6.0 mm; intersection gap, 0.6 mm; matrix, 256 x 192; field of view, 220 x 198 mm; echo-planar imaging factor, 25) sequence was performed to detect hemosiderin deposits. All images were obtained in the transverse plane parallel to the inferior border of the genu and splenium of the corpus callosum.

Areas of hyperintensity were defined as areas of brain parenchyma with increased signal intensity on intermediate, T2-weighted, and FLAIR MR images, and they were rated from hard copies of transverse dual T2-weighted fast spin-echo MR images with the semiquantitative visual scoring system described by Scheltens et al (14). In this scale, the brain is anatomically divided into deep white matter, basal ganglia, and infratentorial regions. For each region, a score of 0–6 is assigned according to the following scale: score 0, absent; score 1, up to five areas of white matter hyperintensity of less than 3 mm in diameter; score 2, six or more areas of white matter hyperintensity of less than 3 mm in diameter; score 3, as many as five areas of white matter hyperintensity of 4–10 mm in diameter; score 4, six or more areas of white matter hyperintensity of 4–10 mm in diameter; score 5, one or more areas of white matter hyperintensity of more than 10 mm in diameter; and score 6, confluent areas of white matter hyperintensity. In addition, scores were assigned to the frontal and occipital periventricular "caps" and periventricular "bands" as follows: score 0, absent; score 1, as much as 5 mm in diameter; and score 2, more than 5 mm in diameter. Because the Scheltens scoring system does not fully reflect the characteristic lesion distribution in patients who have CADASIL, three anatomic locations were added to the Scheltens score: external and internal capsule and the temporal region. The external and internal capsules were assigned separate scores for the presence of areas of subcortical hyperintensity, and the temporal region was assigned a separate score for the presence of areas of periventricular hyperintensity. In our experience, areas of hyperintensity in young patients who have CADASIL often are located in the anterior temporal lobe; for this reason, we assigned separate scores for the presence of areas of hyperintensity in the anterior temporal lobe and the posterior temporal lobe. We defined the border between the anterior temporal lobe and the posterior temporal lobe as the posterior margin of the amygdala (11). To obtain an overall supratentorial lesion load score, the periventricular score was added to the Scheltens subcortical score. To calculate the prevalence of areas of hyperintensity, a Scheltens score of 1 or higher was considered to be positive for areas of hyperintensity, and a score of 0 implied absence of areas of hyperintensity.

Lacunar infarcts were defined as parenchymal defects that did not extend to the cortical gray matter, with a signal intensity similar to that of cerebrospinal fluid with all pulse sequences, irrespective of size. There are three locations where lacunar infarcts can be difficult to distinguish from normal Virchow-Robin spaces: the basal ganglia, the subinsular region, and the semiovale center. To differentiate a lacunar infarct from a Virchow-Robin space, we excluded lesions in the following areas because they were most likely to represent a Virchow-Robin space: (a) basal ganglia—lesions that were isointense to cerebrospinal fluid with all pulse sequences and were located in the lower one-third of the corpus striatum (15,16); (b) subinsular region—areas with a featherlike configuration that were isointense to cerebrospinal fluid on T1- and T2-weighted MR images but did not have high signal intensity on FLAIR images (17); (c) semiovale center—all lesions with a transverse diameter of 2 mm or smaller or with a tubular appearance following the course of perforating arteries (18).

Microbleeds were defined as focal areas of signal intensity loss on T2-weighted fast spin-echo MR images that increased in size on the T2*-weighted gradient-echo images ("blooming effect") (7). In this way, microbleeds were differentiated from areas of signal loss that were based on vascular flow voids. Areas of symmetric hypointensity of the globus pallidus that were likely to represent calcification or nonhemorrhagic iron deposits were excluded.

SLLs were defined as linearly arranged groups of rounded circumscribed lesions that were just below the cortex at the gray matter–white matter junction and had a signal intensity that was identical to that of cerebrospinal fluid with all pulse sequences (9).

One experienced neuroradiologist (M.A.v.B.) who was blinded to the diagnosis of CADASIL assessed the presence of areas of hyperintensity, lacunar infarcts, microbleeds, and SLLs in all 62 participants. For lacunar infarcts and microbleeds, size and number were assessed in the following brain areas: supratentorial region (frontal, temporal, occipital, and parietal lobes and internal and external capsules), infratentorial region (cerebellum, pons, medulla oblongata, and mesencephalon), thalamus, and basal ganglia (globus pallidus, caudate nucleus, and putamen). The presence of SLLs was assessed in each patient who had CADASIL.

Statistical Analyses
Descriptive statistics were obtained in regard to the presence of MR imaging abnormalities in various areas of the brain according to age (percentage of patients affected per anatomic structure per decade). Differences in areas of hyperintensity, lacunar infarcts, and microbleeds between male and female patients who had CADASIL were investigated with the Student t test for unpaired data. Differences in SLLs were tested by using the {chi}2 test. A difference with P < .05 was considered significant. A statistical software package (SPSS-10; SPSS, Chicago, Ill) was used for data analysis.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
One individual did not consent to undergo MR imaging. Of the 62 family members who had CADASIL, 40 individuals had a mutation in the NOTCH3 gene and 22 did not. The mean age of the 40 mutation carriers who were included in our study population was 45 years ± 10 (SD) (range, 21–59 years); 21 women (mean age, 45 years ± 11) and 19 men (mean age, 46 years ± 10) were included. The age and sex distribution of the 40 mutation carriers are listed in the Table. Thirty-two of the 40 NOTCH3 mutation carriers had a mutation in exon 4; the remaining eight patients had mutations in exon 19, 20, 8, or 11. Thirty-two mutation carriers were clinically symptomatic. The symptoms varied in severity, ranging from one transient ischemic attack to multiple strokes and cognitive decline.


View this table:
[in this window]
[in a new window]

 
Baseline Characteristics of NOTCH3 Mutation Carriers according to Age Group

 
MR Imaging
Figure 1 shows the prevalence of areas of hyperintensity, SLLs, lacunar infarcts, and microbleeds among patients of different age groups. Areas of hyperintensity were observed in all mutation carriers. The load of areas of hyperintensity as quantified with the Scheltens score did not differ significantly (P = .5) between men (mean score, 52) and women (mean score, 48). Thirty-two (80%) of 40 mutation carriers had lacunar infarcts, with a mean of 19 (range, 1–60) lacunar infarcts per patient. This group of mutation carriers with lacunar infarcts had a mean age of 49 years ± 6 (age range, 38–59 years). Men had significantly (P = .01) more lacunar infarcts (n = 22) than did women (n = 9). Microbleeds were found in ten (25%) mutation carriers, with a mean age of 53 years ± 5 (age range, 43–58 years). Per patient, a mean of nine microbleeds (range, 1–35) was found. The prevalence of microbleeds did not differ significantly (P = .3) between men and women. Twenty-two (55%) mutation carriers with a mean age of 49 years ± 8 (age range, 25–59 years) had SLLs. SLLs were significantly (P = .02) more prevalent in men (n = 14) than they were in women (n = 8).



View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Graph shows prevalence of areas of hyperintensity (black bars), SLLs (light gray bars), lacunar infarcts (white bars), and microbleeds (dark gray bars) in different age groups. Areas of hyperintensity were present in all mutation carriers. SLLs were found in patients in the 3rd decade and older; lacunar infarcts, in those in the 4th decade and older; and microbleeds, in those in the 5th decade and older.

 
Figure 2 shows the prevalence of areas of hyperintensity in different age groups classified according to the supratentorial white matter, the infratentorial structures, the basal ganglia, and the thalamus. In patients in the 3rd decade, only areas of hyperintensity in the supratentorial white matter were present (Fig 3). Areas of hyperintensity in the infratentorial structures, the basal ganglia, and the thalamus were present in patients in the 4th decade. In the 6th decade, all mutation carriers had areas of hyperintensity in each compartment. To further characterize the distribution of areas of hyperintensity within the supratentorial white matter at different times, we subcategorized this compartment into several anatomic regions and assessed the presence of areas of hyperintensity in the different age groups (Fig 4). In all young mutation carriers, subtle areas of hyperintensity in the anterior temporal lobe were found (Fig 3). Although the occipital lobe was less affected in patients younger than 40 years as compared with other lobes, all lobes were equally affected in patients older than 40 years. Areas of hyperintensity in the external capsule were present in patients older than 30 years; areas of hyperintensity in the internal capsule were seen in patients older than 40 years (Figs 5, 6). Frontal periventricular areas of hyperintensity and periventricular bands were seen in four mutation carriers; temporal periventricular areas of hyperintensity, in two mutation carriers; and occipital periventricular areas of hyperintensity, in one mutation carrier younger than 30 years. The total periventricular Scheltens score in this group varied between 0 and 4. In patients older than 30 years, all mutation carriers had periventricular areas of hyperintensity in every region. With the exception of one mutation carrier who had a score of 3, all other patients had a total periventricular Scheltens score that varied between 6 and 8, the maximal score for periventricular areas of hyperintensity.



View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2. Graph shows prevalence of areas of hyperintensity per location in relation to age. In patients in the 3rd decade, only supratentorial areas of hyperintensity (black bars) were present. With increasing age, areas of hyperintensity were found in other locations too. In patients in the 6th decade, almost all mutation carriers had areas of hyperintensity in every region. Areas of hyperintensity were observed in the following areas: thalamus (white bars), infratentorial region (light gray bars), and basal ganglia (dark gray bars).

 


View larger version (160K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3. Transverse FLAIR MR images (8,000/100/2,000) in NOTCH3 mutation carriers who were 20-30 years old. A, Image shows areas of hyperintensity (arrowhead) in the anterior temporal lobe. B, Image shows SLLs (arrowhead). C, Image shows small ventricular caps (arrowhead). D, Image shows small areas of hyperintensity in the semiovale center (arrowhead).

 


View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4. Graph shows supratentorial areas of hyperintensity distributed among the different regions according to age. In the 3rd decade in all mutation carriers, areas of hyperintensity were observed in the anterior temporal lobe. Areas of hyperintensity were found in the external capsule in patients in the 4th decade and older and in the internal capsule in patients in the 5th decade and older. Areas of hyperintensity were observed in the following regions: frontal lobe (black bars), occipital lobe (dotted bars), parietal lobe (diagonally striped bars), temporal anterior lobe (light gray bars), temporal posterior lobe (horizontally striped bars), internal capsule (white bars), and external capsule (dark gray bars).

 


View larger version (157K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5. A-C, Transverse FLAIR MR images (8,000/100/2,000). D, T2*-weighted gradient-echo MR image (2,598/48). Images obtained in NOTCH3 mutation carriers who were 41-50 years old show confluent areas of hyperintensity in all lobes (A-C). Involvement of the external capsule (arrowhead) is an important feature at this age. Lacunar infarcts (arrow in C) and microbleeds (arrow in D) are present.

 


View larger version (163K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6. A-C, Transverse FLAIR MR images (8,000/100/2,000). D, T2*-weighted gradient-echo MR image (2,598/48). Images obtained in NOTCH3 mutation carriers who were 51-60 years old show complete penetrance of CADASIL: confluent areas of hyperintensity (A-C), lacunar infarcts (arrows in C), SLLs (arrowheads), and microbleeds (arrow in D).

 
Of the total 606 lacunar infarcts, 249 were located in the basal ganglia; lacunar infarcts were also found in the frontal lobe (n = 125), the parietal lobe (n = 129), the temporal lobe (n = 44), the pons (n = 27), the thalamus (n = 22), the cerebellum (n = 5), the occipital lobe (n = 4), and the mesencephalon (n = 1). Only 10 (1.7%) lacunar infarcts were larger than 10 mm in diameter. Figure 7 shows the prevalence of lacunar infarcts per location in the different age groups. The supratentorial lacunar infarcts were seen in patients in the 4th decade, and their prevalence was greater in those during the 5th decade (Figs 5, 6, 8). Lacunar infarcts in the basal ganglia were present in patients in the 4th decade. In patients in the 5th decade, their prevalence was 81%, and this percentage was the same in patients during the 6th decade. In the 6th decade, NOTCH3 mutation carriers had lacunar infarcts in the infratentorial region (53%) and in the thalamus (47%).



View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 7. Graph shows prevalence of lacunar infarcts per location in relation to age. In patients in the 4th decade, lacunar infarcts were present in the supratentorial region (black bars) and in the basal ganglia (dark gray bars). Lacunar lesions in the infratentorial region (light gray bars) and in the thalamus (white bars) were present in patients older than 40 years.

 


View larger version (158K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 8. Transverse FLAIR MR images (8,000/100/2,000) obtained in NOTCH3 mutation carriers who were 31-40 years old. At this age, areas of hyperintensity (arrowhead in A and B) and SLLs (arrow in A) expand from the anterior temporal lobe posteriorly and affect the whole temporal lobe. Areas of hyperintensity in the semiovale center become larger. Areas of hyperintensity in the external capsule (arrowhead in C) and lacunar infarcts (arrow in D) are present.

 
The distribution of the total 85 microbleeds was as follows: thalamus (n = 53), occipital lobe (n = 11), temporal lobe (n = 5), cerebellum (n = 5), brainstem (n = 4), parietal lobe (n = 4), basal ganglia (n = 2), and frontal lobe (n = 1). Seventy-eight (92%) microbleeds were smaller than 5 mm in diameter; the largest was 10 mm in diameter (Figs 5, 6). The prevalence of microbleeds per location in the different age groups is illustrated in Figure 9.



View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 9. Graph shows prevalence of microbleeds per location in relation to age. Microbleeds were present in patients older than 40 years, predominantly in the thalamus (white bars). Graph also shows data for those observed in the following areas: supratentorial region (black bars), infratentorial region (light gray bars), and basal ganglia (dark gray bars).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The spectrum of MR imaging abnormalities in patients who have CADASIL has been described in several studies (412). These abnormalities include areas of hyperintensity, lacunar infarcts, a characteristic pattern of SLLs, and microbleeds. To the best of our knowledge, this study is the first to determine the presence of these lesions, on the basis of radiologic appearances in patients with CADASIL during the 3rd, 4th, 5th, and 6th decades.

As early as the 3rd decade, cerebral abnormalities can be found in patients who have CADASIL. In this study, supratentorial areas of hyperintensity were observed in all patients, and SLLs were observed in one patient. A notable site of predilection of the areas of hyperintensity is the anterior temporal lobe. These areas of hyperintensity are found in all patients of this age group, invariably as a highly characteristic pattern of bilateral hyperintense areas located directly below the cortical ribbon. Although this type of abnormality has been described by others (12) as a characteristic finding in patients who have CADASIL, the early involvement of the anterior temporal lobe has not been reported before, to our knowledge. A pattern of multiple, although often few, small patches with high signal intensity was observed in other locations. Periventricular white matter areas of hyperintensity are frequently seen as smooth caps around the frontal horns and seldom are seen around the posterior and temporal horn of the lateral ventricles. In young patients, SLLs were another characteristic observation, and SLLs always were observed in conjunction with the observation of areas of hyperintensity in the anterior temporal lobe. SLLs are a recently described abnormality that is considered to be specific for CADASIL (9). The radiologic phenomenon of SLLs is based on the presence of dilated perivascular spaces of perforating arteries at the level of the gray matter–white matter junction and spongiosis in the surrounding parenchyma. Detection of areas of hyperintensity with or without SLLs in the anterior temporal lobes in young patients is highly characteristic of findings in young patients with CADASIL, and detection of these areas of hyperintensity suggests the diagnosis.

In the 4th decade, in addition to areas of hyperintensity and SLLs, lacunar infarcts were seen in patients who have CADASIL. These lacunar infarcts are found in 75% of patients of this age group, and they occur in the supratentorial white matter and in the basal ganglia. In the supratentorial white matter, areas of hyperintensity in the external capsule are a new finding in this age group, and this finding can be observed in 25% of patients. The prevalence of subcortical areas of hyperintensity increases in all lobes, and larger periventricular areas of hyperintensity are present. Subcortical and periventricular areas of hyperintensity may become confluent. The areas of hyperintensity in the anterior temporal lobe increase in size and expand posteriorly in the temporal lobe. Apart from the supratentorial white matter, areas of hyperintensity are now also observed in the basal ganglia, the thalamus, and the brainstem. Although the number of patients in whom SLLs are observed does not increase, the number of SLLs per patient is higher than it is in the preceding age group, and the distribution of SLLs follows the expanding white matter areas of hyperintensity of the anterior temporal lobes.

In patients in the 5th decade, microbleeds may be observed in addition to areas of hyperintensity, SLLs, and lacunar infarcts. Microbleeds are found in 19% of patients in this age group, and they can be observed in the thalamus, the brainstem, and the supratentorial white matter. The number of patients in whom areas of hyperintensity are observed further increases, although there are still patients in whom areas of hyperintensity are not observed in the infratentorial white matter, in the basal ganglia, or in the thalamus. The number and size of areas of hyperintensity further increase, giving rise to large confluent areas of high signal in subcortical and periventricular white matter. Areas of hyperintensity can also involve the internal capsule. The prevalence of lacunar infarcts (94%) and SLLs (56%) increases. Now lacunar infarcts also are present in the brainstem and the thalamus.

In patients in the 6th decade, no new types of lesions are seen, and areas of hyperintensity, SLLs, lacunar infarcts, and microbleeds are observed in most patients. Areas of hyperintensity are always found in all lobes, in the brainstem, in the basal ganglia, and in the thalamus. In almost all cases, areas of hyperintensity are also found in the internal and external capsule. During this stage, most of the supratentorial white matter may show a symmetric pattern of large homogeneous areas of increased signal intensity involving the subcortical and periventricular white matter. Lacunar infarcts are found in more than 90% of cases. SLLs are found in 73% of cases; microbleeds, in 47%. SLLs may now be observed in the temporal lobe, in the subinsular white matter, and in the operculum of the frontal lobe.

In patients older than 30 years, CADASIL shares several radiologic characteristics with other diseases accompanied by small vessel disease, which implies that differentiating CADASIL from these disorders based on findings of radiologic examinations may be difficult. Nonspecific areas of hyperintensity in the periventricular, the frontal, the parietal, and the occipital regions are seen in a number of other small vessel diseases (19). Brainstem abnormalities located predominantly at the rostrocaudal center of the pons are frequently observed in patients who have CADASIL, but they can also be found in patients who have atherosclerosis (20). The occurrence of lacunar infarcts and microbleeds is also considered to be characteristic of cerebral small vessel disease in general and is not characteristic of only CADASIL (21,22). Still, the distribution of the areas of hyperintensity and the presence of SLLs seem to specifically suggest the diagnosis of CADASIL. By using image postprocessing software that is based on statistical parametric mapping, Auer et al (12) compared patterns of areas of hyperintensity in a group of patients who had CADASIL and a group of patients who had Binswanger disease. In that study, it was suggested that the presence of white matter areas of hyperintensity in the anterior temporal lobe was characteristic of patients who had CADASIL (12). The image processing technique used in that study only permitted detection of differences between groups and did not help in determination of the diagnosis in patients. In our study, the characteristic areas of hyperintensity in the anterior temporal lobe were present in 39 of 40 patients who had CADASIL, and this result demonstrates that the prevalence of this finding in patients who have CADASIL is high, which makes it a useful radiologic hallmark of the disease. The presence of areas of hyperintensity in the external capsule also has been described to be characteristic of CADASIL (11). Because of its high prevalence (94%) among patients with CADASIL after the age of 40, this is another sign that is helpful in the suggestion of the diagnosis later during the course of the disease. Finally, the prevalence of SLLs increases considerably in patients older than 40 years, and therefore, this lesion is helpful for detection of the disease in patients with increasing age.

In our study, men were more frequently affected by lacunar infarcts and SLLs than were women. For this observation, there is no simple explanation. A difference in age at death between men and women who have CADASIL has been found (1). Death occurs at a significantly younger age in men, and although this difference may reflect the generally observed difference in life expectancy, it may also be caused by differences in the disease dynamics in men and women.

In summary, in patients who have CADASIL, imaging abnormalities are found in the brain earlier than expected clinically. In young patients who have CADASIL, cerebral abnormalities are highly characteristic, although limited. The areas of hyperintensity in the anterior temporal lobe and the SLLs that are observed in these young patients continue to help in the recognition of the underlying condition later in life.


    FOOTNOTES
 
Abbreviations: CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, FLAIR = fluid-attenuated inversion recovery, SLL = subcortical lacunar lesion

Author contributions: Guarantors of integrity of entire study, R.v.d.B., M.A.v.B.; study concepts, R.v.d.B., M.A.v.B., J.H.; study design, R.v.d.B., M.A.v.B.; literature research, R.v.d.B., M.A.v.B.; clinical studies, R.v.d.B., S.A.J.L.O.; data acquisition, R.v.d.B., S.A.J.L.O.; data analysis/interpretation, R.v.d.B., M.A.v.B.; statistical analysis, R.v.d.B., M.A.v.B.; manuscript preparation and definition of intellectual content, R.v.d.B, M.A.v.B.; manuscript editing, R.v.d.B.; manuscript revision/review, M.A.v.B, M.D.F., J.H.; manuscript final version approval, all authors


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Joutel A, Corpechot C, Ducros A, et al. NOTCH3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383:707-710.[CrossRef][Medline]
  2. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: a clinicopathological study. Stroke 1993; 24:122-125.[Abstract/Free Full Text]
  3. Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families—cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995; 346:934-939.[CrossRef][Medline]
  4. Skehan SJ, Hutchinson M, MacErlaine DP. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. AJNR Am J Neuroradiol 1995; 16:2115-2119.[Abstract]
  5. Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998; 51:452-457.[Abstract/Free Full Text]
  6. Yousry TA, Seelos K, Mayer M, et al. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 1999; 20:91-100.[Abstract/Free Full Text]
  7. Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001; 57:1066-1070.[Abstract/Free Full Text]
  8. Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke 2002; 33:67-71.[Abstract/Free Full Text]
  9. van den Boom R, Lesnik Oberstein SA, van Duinen SG, et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology 2002; 224:791-796.[Abstract/Free Full Text]
  10. Coulthard A, Blank SC, Bushby K, Kalaria RN, Burn DJ. Distribution of cranial MRI abnormalities in patients with symptomatic and subclinical CADASIL. Br J Radiol 2000; 73:256-265.[Abstract]
  11. O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001; 56:628-634.[Abstract/Free Full Text]
  12. Auer DP, Putz B, Gossl C, Elbel GK, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001; 218:443-451.[Abstract/Free Full Text]
  13. Lesnik Oberstein SA, Ferrari MD, Bakker E, et al. Diagnostic NOTCH3 sequence analysis in CADASIL: three new mutations in Dutch patients—Dutch CADASIL Research Group. Neurology 1999; 52:1913-1915.[Abstract/Free Full Text]
  14. Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993; 114:7-12.[CrossRef][Medline]
  15. Jungreis CA, Kanal E, Hirsch WL, Martinez AJ, Moossy J. Normal perivascular spaces mimicking lacunar infarction: MR imaging. Radiology 1988; 169:101-104.[Abstract/Free Full Text]
  16. Heier LA, Bauer CJ, Schwartz L, Zimmerman RD, Morgello S, Deck MD. Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol 1989; 10:929-936.[Abstract]
  17. Song CJ, Kim JH, Kier EL, Bronen RA. MR imaging and histologic features of subinsular bright spots on T2-weighted MR images: Virchow-Robin spaces of the extreme capsule and insular cortex. Radiology 2000; 214:671-677.[Abstract/Free Full Text]
  18. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol 1998; 245:116-122.[CrossRef][Medline]
  19. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28:652-659.[Abstract/Free Full Text]
  20. Kwa VI, Stam J, Blok LM, Verbeeten B, Jr. T2-weighted hyperintense MRI lesions in the pons in patients with atherosclerosis: Amsterdam Vascular Medicine Group. Stroke 1997; 28:1357-1360.[Abstract/Free Full Text]
  21. Lammie GA. Pathology of small vessel stroke. Br Med Bull 2000; 56:296-306.[Abstract/Free Full Text]
  22. Kwa VI, Franke CL, Verbeeten B, Jr, Stam J. Silent intracerebral microhemorrhages in patients with ischemic stroke: Amsterdam Vascular Medicine Group. Ann Neurol 1998; 44:372-377.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
M.K. Liem, S.A.J. Lesnik Oberstein, J. Haan, R.v.d. Boom, M.D. Ferrari, M.A.v. Buchem, and J.v.d. Grond
Cerebrovascular Reactivity Is a Main Determinant of White Matter Hyperintensity Progression in CADASIL
AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1244 - 1247.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Putaala, M. Kurkinen, V. Tarvos, O. Salonen, M. Kaste, and T. Tatlisumak
Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke
Neurology, May 26, 2009; 72(21): 1823 - 1829.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. D. Brass, E. E. Smith, J. F. Arboleda-Velasquez, W. A. Copen, and M. P. Frosch
Case 12-2009 -- A 46-Year-Old Man with Migraine, Aphasia, and Hemiparesis and Similarly Affected Family Members
N. Engl. J. Med., April 16, 2009; 360(16): 1656 - 1665.
[Full Text] [PDF]


Home page
NeurologyHome page
M. Liguori, R. Mazzei, C. Ungaro, I. L. Simone, A. Gambardella, I. Plasmati, F. Fera, U. Aguglia, P. Lanza, F. Bono, et al.
CONVENTIONAL MRI AND NOTCH3 GENE SCREENING IN SPORADIC CADASIL
Neurology, February 3, 2009; 72(5): 469 - 471.
[Full Text] [PDF]


Home page
RadiologyHome page
M. K. Demir
Case 142: Susac Syndrome
Radiology, February 1, 2009; 250(2): 598 - 602.
[Full Text] [PDF]


Home page
NeurologyHome page
M. K. Liem, S.A.J. Lesnik Oberstein, J. Haan, I. L. van der Neut, M. D. Ferrari, M. A. van Buchem, H. A.M. Middelkoop, and J. van der Grond
MRI correlates of cognitive decline in CADASIL: A 7-year follow-up study
Neurology, January 13, 2009; 72(2): 143 - 148.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M L Stromillo, M T Dotti, M Battaglini, M Mortilla, S Bianchi, K Plewnia, L Pantoni, D Inzitari, A Federico, and N De Stefano
Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy
J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 41 - 47.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. K. Liem, S. A. J. Lesnik Oberstein, J. Haan, I. L. van der Neut, R. van den Boom, M. D. Ferrari, M. A. van Buchem, and J. van der Grond
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Progression of MR Abnormalities in Prospective 7-year Follow-up Study
Radiology, December 1, 2008; 249(3): 964 - 971.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Scheid, W. Heinritz, T. Leyhe, D. R. Thal, R. Schober, S. Strenge, D. Y. von Cramon, and U. G. Froster
CYSTEINE-SPARING NOTCH3 MUTATIONS: CADASIL OR CADASIL VARIANTS?
Neurology, September 2, 2008; 71(10): 774 - 776.
[Full Text] [PDF]


Home page
BrainHome page
C. Cordonnier, R. Al-Shahi Salman, and J. Wardlaw
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting
Brain, August 1, 2007; 130(8): 1988 - 2003.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. K. Liem, J. van der Grond, J. Haan, R. van den Boom, M. D. Ferrari, Y. M. Knaap, M. H. Breuning, M. A. van Buchem, H. A.M. Middelkoop, and S. A.J. Lesnik Oberstein
Lacunar Infarcts Are the Main Correlate With Cognitive Dysfunction in CADASIL
Stroke, March 1, 2007; 38(3): 923 - 928.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Opherk, N. Peters, M. Holtmannspotter, A. Gschwendtner, B. Muller-Myhsok, and M. Dichgans
Heritability of MRI Lesion Volume in CADASIL: Evidence for Genetic Modifiers
Stroke, November 1, 2006; 37(11): 2684 - 2689.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Linnankivi, L. Valanne, A. Paetau, I. Alafuzoff, J. M. Hakumaki, T. Kivela, T. Lonnqvist, O. Makitie, L. Paakkonen, L. Vainionpaa, et al.
Cerebroretinal microangiopathy with calcifications and cysts
Neurology, October 24, 2006; 67(8): 1437 - 1443.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al.
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study
Brain, September 1, 2006; 129(9): 2375 - 2383.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Kim, E. J. Choi, C. G. Choi, G. Kim, J. H. Choi, H. W. Yoo, and J. S. Kim
Characteristics of CADASIL in Korea: A novel cysteine-sparing Notch3 mutation
Neurology, May 23, 2006; 66(10): 1511 - 1516.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Peters, M. Holtmannspotter, C. Opherk, A. Gschwendtner, J. Herzog, P. Samann, and M. Dichgans
Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease
Neurology, May 23, 2006; 66(10): 1517 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. van den Boom, S.A.J. Lesnick Oberstein, A.A. van den Berg-Huysmans, M.D. Ferrari, M.A. van Buchem, and J. Haan
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Structural MR Imaging Changes and Apolipoprotein E Genotype.
AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 359 - 362.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Viswanathan and H. Chabriat
Cerebral Microhemorrhage
Stroke, February 1, 2006; 37(2): 550 - 555.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. G. Marrosu, G. Floris, G. Costa, L. Schirru, G. Spinicci, M. V. Cherchi, M. Mura, M. G. Mascia, and E. Cocco
Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation
Neurology, January 10, 2006; 66(1): 108 - 111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Singhal, P. Rich, and H. S. Markus
The Spatial Distribution of MR Imaging Abnormalities in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and Their Relationship to Age and Clinical Features
AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2481 - 2487.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. J. Choi, C. G. Choi, and J. S. Kim
Large cerebral artery involvement in CADASIL
Neurology, October 25, 2005; 65(8): 1322 - 1324.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Opherk, N. Peters, J. Herzog, R. Luedtke, and M. Dichgans
Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients
Brain, November 1, 2004; 127(11): 2533 - 2539.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. F. Meschia
Clinically Translated Ischemic Stroke Genomics
Stroke, November 1, 2004; 35(11_suppl_1): 2735 - 2739.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. C. Kruit, M. A. van Buchem, M. D. Ferrari, and L. J. Launer
Migraine as a Risk Factor for Subclinical Brain Lesions--Reply
JAMA, May 5, 2004; 291(17): 2072 - 2073.
[Full Text] [PDF]


Home page
NeurologyHome page
M. G. Marrosu, G. Floris, G. Costa, L. Schirru, G. Spinicci, M. V. Cherchi, M. Mura, M. G. Mascia, and E. Cocco
Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation
Neurology, January 10, 2006; 66(1): 108 - 111.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2293021354v1
229/3/683    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Boom, R.
Right arrow Articles by van Buchem, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Boom, R.
Right arrow Articles by van Buchem, M. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE